Atrasentan hydrochloride 10mg
Atrasentan hydrochloride is an endothelin antagonist receptor (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
Trivial name | Atrasentan hydrochloride 10mg |
Catalog Number | A15007-10 |
Alternative Name(s) | (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid,hydrochloride |
Molecular Formula | C29H39ClN2O6 |
CAS# | 195733-43-8 |
SMILES | CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl |
Size | 10mg |
Supplier Page | http://www.adooq.com/atrasentan-hydrochloride.html |